|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.70 USD | -0.54% |
|
-3.61% | -7.62% |
| Market Cap | 4.25B 3.74B 3.47B 3.2B 5.99B 412B 6.1B 41.54B 16.2B 201B 15.96B 15.62B 697B | P/E 2026 * |
63.2x | P/E 2027 * | 31.8x |
|---|---|---|---|---|---|
| Enterprise Value | 3.28B 2.89B 2.68B 2.47B 4.62B 318B 4.71B 32.07B 12.51B 155B 12.32B 12.05B 538B | EV / Sales 2026 * |
2.64x | EV / Sales 2027 * | 2.19x |
| Free-Float |
99.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACADIA Pharmaceuticals Inc.
| 1 day | -0.46% | ||
| 1 week | -3.61% | ||
| Current month | -2.47% | ||
| 1 month | +5.63% | ||
| 3 months | +12.36% | ||
| 6 months | -8.13% | ||
| Current year | -7.62% |
| 1 week | 24.23 |  | 26.16 |
| 1 month | 23.28 | | 27.31 |
| Current year | 19.89 | | 27.81 |
| 1 year | 19.69 | | 28.35 |
| 3 years | 13.4 | | 32.59 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Catherine Adams
CEO | Chief Executive Officer | 55 | 20/09/2024 |
Mark Schneyer
DFI | Director of Finance/CFO | 52 | 10/09/2021 |
Scott Cenci
CTO | Chief Tech/Sci/R&D Officer | - | 04/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
BRD | Director/Board Member | 68 | 01/05/2008 |
Stephen Biggar
CHM | Chairman | 55 | 10/06/2016 |
Edmund Harrigan
BRD | Director/Board Member | 73 | 25/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/26/26 A | Sell | Controller/Auditor | -11,421 | 0.0067% | ||
| 5/29/26 A | Baker Bros. Advisors LP
| Free | Company | 101,260 | 0.0591% | |
| 5/29/26 A | Fiscal year | Director | 41,529 | 0.0243% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.54% | -3.61% | +7.05% | -17.80% | 4.25B | |
| +1.00% | -3.80% | -3.57% | +12.50% | 46.35B | |
| +0.20% | +1.13% | +405.83% | +625.79% | 40.13B | |
| +0.23% | +4.65% | +10.15% | +67.25% | 36.33B | |
| +1.21% | +1.45% | +4.20% | -8.29% | 34.6B | |
| +3.14% | +1.02% | +3.72% | +34.86% | 26.77B | |
| +1.27% | -2.26% | - | - | 16.66B | |
| -0.60% | +11.86% | +32.00% | +143.58% | 16.91B | |
| -0.12% | -6.06% | +0.18% | +7.88% | 13.05B | |
| -0.85% | -0.83% | -13.55% | -30.52% | 13.05B | |
| Average | +0.50% | +0.60% | +49.56% | +92.81% | 24.81B | |
| Weighted average by Cap. | +0.74% | +0.70% | +74.02% | +133.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.24B 1.09B 1.01B 933M 1.75B 120B 1.78B 12.13B 4.73B 58.64B 4.66B 4.56B 203B | 1.4B 1.23B 1.14B 1.05B 1.97B 136B 2.01B 13.68B 5.34B 66.16B 5.26B 5.14B 230B |
| Net income | 67.44M 59.31M 55.1M 50.68M 95.03M 6.53B 96.74M 659M 257M 3.19B 253M 248M 11.05B | 142M 125M 116M 107M 200M 13.74B 204M 1.39B 541M 6.7B 533M 521M 23.25B |
| Net Debt | -970M -853M -792M -729M -1.37B -93.93B -1.39B -9.48B -3.7B -45.81B -3.64B -3.56B -159B | -1.18B -1.04B -967M -889M -1.67B -115B -1.7B -11.56B -4.51B -55.88B -4.44B -4.35B -194B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | $24.67 | -0.64% | 100,490 |
| 23/07/26 | $24.83 | -0.52% | 1,272,018 |
| 22/07/26 | $24.96 | -1.85% | 1,163,336 |
| 21/07/26 | $25.43 | +1.36% | 1,340,502 |
| 20/07/26 | $25.09 | -1.99% | 1,486,529 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACAD Stock
Select your edition
All financial news and data tailored to specific country editions
